ULTRAGREEN AI USD(ULG.SG)

Last Updated 07:30:00 SGT
longbridge loading
Company Encyclopedia
View More
name
ULTRAGREEN AI USD
ULG.SG
UltraGreen.ai Limited manufactures fluorescence imaging surgical devices and pharmaceutical agents. Its products include indocyanine green, a fluorescent imaging agent used in FGS and ophthalmology; IC-Flow imaging system, a small, compact handheld NIR device that visualizes and records tissue fluorescence; fluorescein, an ophthalmic contrast agent for perfusion and abnormalities visualization ; and ephedrine, a medicine to increase blood pressure in surgeries. In addition, the company provides quantification software that allows real-time, quantitative perfusion assessment and tumor identification; UltraLinQ, an imaging software for visualization, and augmented reality glasses that projects real-time surgical images and virtual guidance for physicians. UltraGreen.ai Limited was incorporated in 2024 and is based in Singapore with additional offices in USA and Europe.
4.910 B
ULG.SGMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    UltraGreen.ai secures dual regulatory approvals in Philippines and Malaysia

    UltraGreen.ai Limited, a Singapore-based firm, has secured regulatory approvals for its Verdye (indocyanine green for injection) in the Philippines and IC-Flow Imaging System V2 in Malaysia. These approvals mark a significant step in the company's expansion in Southeast Asia, addressing the growing healthcare demand. The approvals will enable UltraGreen to support education and clinical adoption of fluorescence-guided surgery techniques. The company aims to enhance surgical decision-making and patient care through its products and AI-powered data platform, reinforcing its commitment to advancing precision surgery in the region.

    动点科技英文源·
    SG
    ULG
    +5.77%
    动点科技英文源·
    SG
    ULG
    +5.77%

    UltraGreen.ai Wins Key Regulatory Approvals in Philippines and Malaysia to Drive Fluorescence-Guided Surgery Expansion

    UltraGreen.ai Limited has received regulatory approvals for its Verdye indocyanine green injectable in the Philippines and the IC-Flow Imaging System V2 in Malaysia. This marks a significant milestone in the company's efforts to expand fluorescence-guided surgery in Southeast Asia, enhancing surgical education and training while strengthening its market position. UltraGreen.ai specializes in fluorescence-guided surgery and digital health solutions, focusing on high-growth healthcare markets in the region.

    Tip Ranks·
    SG
    ULG
    +5.77%
    Tip Ranks·
    SG
    ULG
    +5.77%

    UltraGreen.ai closes week below IPO price; MetaOptics surges

    UltraGreen.ai's shares closed below IPO price at US$1.44, despite initial gains. MetaOptics surged 76% over the week, closing at $1.26, after announcing a share placement. SGX highlighted the 30 most traded stocks outside STI, with S-Reits leading. Manulife US Reit seeks to expand its investment mandate. OCBC's stock reached a new high, while Marco Polo Marine reported a 30% increase in core earnings.

    Straitstimes·
    SG
    ULG
    +5.77%
    Straitstimes·
    SG
    ULG
    +5.77%
    © 2026 Longbridge｜Disclaimer